Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
100,4 SEK | 0,00% | -0,50% | -21,01% |
Vakgebied
Aantal werknemers: 181
Verkoop per activiteit
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Out-licensing of the Product Candidate
52,5
%
| 225 | 98,2 % | 422 | 52,5 % | +87,21% |
Therapeutics for Renal Disease Immunoglobulin
46,8
%
| - | - | 376 | 46,8 % | - |
Performance of Certain Regulatory Services
0,4
%
| 4 | 1,8 % | 3 | 0,4 % | -17,29% |
Royalty
0,3
%
| - | - | 2 | 0,3 % | - |
Verkoop per regio
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
46,4
%
| - | - | 372 | 46,4 % | - |
Asia
35,7
%
| 27 | 12,0 % | 287 | 35,7 % | +943,64% |
Europe
17,9
%
| 202 | 88,0 % | 144 | 17,9 % | -28,69% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 18-05-17 | |
Director of Finance/CFO | 47 | 01-08-17 | |
Chief Tech/Sci/R&D Officer | 60 | 24-07-20 | |
Chief Tech/Sci/R&D Officer | - | 01-03-19 | |
Chief Tech/Sci/R&D Officer | 65 | 01-04-07 | |
Åsa Hillsten
IRC | Investor Relations Contact | - | 01-04-23 |
Monika Tornsen
PRN | Corporate Officer/Principal | 45 | 07/01 |
Christopher Ngai
PRN | Corporate Officer/Principal | - | 01-04-20 |
Frank Bringstrup
LAW | General Counsel | 65 | 01-02-19 |
Anders Hultman
PRN | Corporate Officer/Principal | 50 | 01-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 30-05-23 |
Henrik Stenqvist
BRD | Director/Board Member | 57 | 01-01-22 |
Elmar Schnee
CHM | Chairman | 65 | 08-05-19 |
Hilde Furberg
BRD | Director/Board Member | 65 | 01-09-14 |
Director/Board Member | 62 | 01-01-22 | |
Diane Parks
BRD | Director/Board Member | 71 | 08-05-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 59 580 087 | 43 663 885 ( 73,29 %) | 5 908 018 ( 9,916 %) | 73,29 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
5 908 018 | 9.92% | 62 657 308 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,01% | 498 mln. | |
+5,73% | 71,48 mld. | |
+11,94% | 9,18 mld. | |
-15,34% | 4,79 mld. | |
+34,54% | 3,98 mld. | |
+5,09% | 3,97 mld. | |
+27,76% | 2,56 mld. | |
-28,33% | 2,29 mld. | |
-24,15% | 2,23 mld. | |
+6,23% | 1,92 mld. |
- Beurs
- Aandelen
- Koers CALTX
- Onderneming Calliditas Therapeutics AB